Price Target Update on Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) plundered a cool -2.43% with the closing price of $18.90 as of morning trading. The overall volume in the last trading session was 2.7 million shares. ROI is a form of ... [Read]
Before Investing in Community Health Systems Inc: Understand Beta
If you are interested in investing in Community Health Systems Inc. (NYSE:$CYH) or currently own the stock, then you must understand its beta in order to successfully minimize risks to your portfolio. Specifically, there are ... [Read]
Call Dates and 3rd Quarter Earnings Set by Ashford Hospitality Trust
It was announced that Ashford Hospitality Hospitality Trust (NYSE:$AHT) has set dates for its 3rd quarter. Its 3rd quarter ended on September 30, 2017. The report will be officially released by Ashford Trust when the ... [Read]
SunPower Corporation Registers a 2.84% Price Change After Morning Session
As of morning trading, SunPower Corporation (NASDAQ:$SPWR) stock saw a move of 2.84% with the closing price of $6.87. During the past week, the company saw a total shift of 1.93%. Over the last three ... [Read]
Head-to-Head: Axcelis Technologies VS Xcerra Corporation
When it comes to small-cap computer technology companies, Xcerra Corporation (NASDAQ:$XCRA) and Axcelis Technologies (NASDAQ:$ACLS) are two contenders. How do they stack up against each other, though? Let’s look at the stats of these two ... [Read]
3D Signatures Announces Successful Clinical Trial Completion in New Lymphoma Drug
3D Signatures, Inc. (TSXV:DXD) officially announced that the company had completed the clinical trial component, or Stage 3, of its Hodgkin’s lymphoma test validation program. Data from the clinical trial has been further submitted to ... [Read]
Imperva, Inc. Expected to Report Upwards of $83.07 Million in Sales This Quarter
According to the Zacks Investment Research report, Equities analysts forecast that Imperva, Inc. (NYSE:$IMPV) will see sales of $83.07 million for the current quarter. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales ... [Read]
Head-to-Head: Impax Laboratories VS. SCYNEXIS
Impax Laboratories (NASDAQ:$IPXL) and SCYNEXIS (NASDAQ:$SCYX) are both small-cap companies competing in the medical sector. So how do these two rivals stack up against each other? Let’s look at the numbers. Profitability Impax Laboratories has ... [Read]
Snapdragon 660 Mobile Platform To Be Included in New Intrinsyc Hardware Development Kit
On Monday, Intrinsyc Technologies Corporation (TSXV:ITC), announced that it was releasing a new Hardware Development Kit featuring the Qualcomm (NASDAQ:$QCOM) Snapdragon 660 Mobile Platform. Intrinsyc is a leading developer of intelligent connected devices. Intrinsyc also ... [Read]
Anavex Life Sciences Corp.: Top Holders Statistics
Anavex Life Sciences Corp. (NASDAQ:$AVXL) reached 75.36% versus a 1-year low price of $2.76. On October 20th, the stock was last seen 3.64% higher, reaching at $4.84. At the most recent session, Anavex shares are ... [Read]